Emergency ponatinib 45 MG tablets - fargo
Ended Awarded Last action
- Contract number
- 36C26322F0032
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $36,808
Award facts
- Contract value 100% obligated
- $36,808.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$110,424 | |
| Other Administrative Action | $0 | |
| Original award | $147,232 |
About this award
This delivery order from the Department of Veterans Affairs Veterans Health Administration awards Takeda Pharmaceuticals America, Inc. $36,808.10 to supply emergency ponatinib 45 mg tablets. Takeda Pharmaceuticals America, a foreign-owned manufacturer, will deliver the products under a firm fixed price contract by September 30, 2022. The award draws from Takeda's multiple award Federal Supply Schedule contract for Pharmaceuticals and Drugs, which has no set-aside designation. Takeda currently holds an active blanket purchase agreement valued at over $13 million with the VA National Acquisition Center through October 2024 to provide ponatinib products to VA medical networks, including those serving regions in New England and Ohio. As a longstanding supplier of specialty pharmaceuticals, Takeda supports the VA's healthcare mission for veterans through major purchasing vehicles and delivery orders for critical oncology medications.
Quick answers
Who was awarded contract 36C26322F0032?
36C26322F0032 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on February 24, 2022.
How much is contract 36C26322F0032 worth?
The government has obligated $36,808 on 36C26322F0032.
Is contract 36C26322F0032 an order under another contract?
Yes. 36C26322F0032 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26322F0032 competed?
The extent of competition for 36C26322F0032 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award